Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 11, Issue 17, 2001, Pages 2229-2234

  Ludovici, Donald W ^a   Kavash, Robert W ^a   Kukla, Michael J ^a   Ho, Chih Y ^a   Ye, Hong ^a   De Corte, Bart L ^a   Andries, Koen ^b   De Béthune, Marie Pierre ^c   Azijn, Hilde ^c   Pauwels, Rudi ^c   Moereels, Henry E L ^b   Heeres, Jan ^b   Koymans, Lucien M H ^b   De Jonge, Marc R ^b   Van Aken, Koen J A ^b   Daeyaert, Frederik F D ^b   J Lewi, Paul ^b   Das, Kalyan ^d   Arnold, Edward ^d   Janssen, Paul A J ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c Virco BVBA   (Belgium)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDOYLTHIOUREA DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIOUREA DERIVATIVE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRUS INHIBITION;

ANTI-HIV AGENTS; DRUG DESIGN; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; INHIBITORY CONCENTRATION 50; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES;

EID: 17944366732     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(01)00411-5     Document Type: Article

References (10)